Search results
Results from the WOW.Com Content Network
Fugl-Meyer Assessment (FMA) scale is an index to assess the sensorimotor impairment in individuals who have had stroke. [1] This scale was first proposed by Axel Fugl-Meyer and his colleagues as a standardized assessment test for post-stroke recovery in their paper titled The post-stroke hemiplegic patient: A method for evaluation of physical performance.
Around the same time, Brunnstrom also described the process of recovery, and divided the process into seven stages. As knowledge of the science of brain recovery improved, intervention strategies have evolved. Knowledge of strokes and the process of recovery after strokes has developed significantly in the late 20th century and early 21st century.
The Brunnstrom Approach follows six proposed stages of sequential motor recovery after a stroke. A patient can plateau at any of these stages, but will generally follow this sequence if he or she makes a full recovery. [1] [2] The variability found between patients depends on the location and severity of the lesion, and the potential for ...
The researchers sought to predict the risk of major cardiac events with a 30-year follow-up period using a blood test. At the time, the average participant age was 54.7 years.
Tesla stock closed 5.7% lower on Thursday after Reuters reported Trump's team has drawn up plans to eliminate the $7,500 tax credit for electric vehicle buyers as part of a broader tax reform.
Walmart said it is testing employees wearing body cameras in one U.S. market in a "handful of stores" as a way to protect its employees.
And thus it was thought that the pain associated after stroke was part of the stroke and lesion repair process occurring in the brain. [ medical citation needed ] It is now accepted that Dejerine–Roussy syndrome is a condition developed due to lesions interfering with the sensory process, which triggered the start of pharmaceutical and ...
The Ontario Stroke Registry (formerly the Registry of the Canadian Stroke Network (RCSN)) was established in 2001 to allow for the measurement and monitoring of stroke care delivery and outcomes in Canadian patients at participating institutions, and to serve as a rich clinical database for investigator-initiated research projects.